Kohki Nakamura1, Shigeto Naito2, Takehito Sasaki2, Masahiro Nakano2, Kentaro Minami2, Yosuke Nakatani2, Kentaro Ikeda2, Eiji Yamashita2, Koji Kumagai2, Nobusada Funabashi3, Shigeru Oshima2. 1. Division of Cardiology, Gunma Prefectural Cardiovascular Center, 3-12 Kameizumi-machi, Maebashi City, Gunma, 371-0004, Japan. kohkinakamura@yahoo.co.jp. 2. Division of Cardiology, Gunma Prefectural Cardiovascular Center, 3-12 Kameizumi-machi, Maebashi City, Gunma, 371-0004, Japan. 3. Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-8670, Japan.
Abstract
PURPOSE: We prospectively investigated the differences in pulmonary vein reconnections (PVRs) and clinical outcomes between contact force (CF)-guided and conventional circumferential PV isolation (CPVI) of atrial fibrillation (AF). METHODS:One hundred twenty consecutive AF patients (63 ± 10 years; 88 males) undergoing an initial CPVI were randomized to ablation with a target CF of 20 g (CF group; n = 60) or that with operators blinded to the CF information (blind group; n = 60). RESULTS: The CF group had fewer PVRs (0.67 ± 0.91/patient vs. 1.16 ± 1.16/patient; P = 0.007), a lower incidence of persistent PVRs (13.2 vs. 41.2%; P < 0.001), and a shorter procedural time for the CPVI (50 vs. 56 min; P = 0.019) than the blind group. The mean CF was higher in the CF group than the blind group (18.0 vs. 16.1 g; P < 0.001), with the most significant difference observed along the posterior right-sided PVs (P-RPVs) and anterior left-sided PVs (A-LPVs). In logistic regression models, the mean CF was a negative predictor of PVRs along the P-RPVs and A-LPVs in the blind group (odds ratios, 0.728 and 0.786; P < 0.001 and 0.007), while no significant predictor was identified in the CF group or elsewhere in the blind group. In the Kaplan-Meier analysis, the arrhythmia-free survival rate at 12 months was 89.9% in the CF group and 88.2% in the blind group, respectively (P = 0.624). CONCLUSIONS:CF-guided CPVI can reduce PVRs and the procedural time and be particularly beneficial along regions where a relatively low CF tends to be applied: the P-RPVs and A-LPVs. The comparable clinical outcomes may be due to the learning curve effect obtained by the CF-guided technique and repeated provocation of dormant PV conduction.
RCT Entities:
PURPOSE: We prospectively investigated the differences in pulmonary vein reconnections (PVRs) and clinical outcomes between contact force (CF)-guided and conventional circumferential PV isolation (CPVI) of atrial fibrillation (AF). METHODS: One hundred twenty consecutive AFpatients (63 ± 10 years; 88 males) undergoing an initial CPVI were randomized to ablation with a target CF of 20 g (CF group; n = 60) or that with operators blinded to the CF information (blind group; n = 60). RESULTS: The CF group had fewer PVRs (0.67 ± 0.91/patient vs. 1.16 ± 1.16/patient; P = 0.007), a lower incidence of persistent PVRs (13.2 vs. 41.2%; P < 0.001), and a shorter procedural time for the CPVI (50 vs. 56 min; P = 0.019) than the blind group. The mean CF was higher in the CF group than the blind group (18.0 vs. 16.1 g; P < 0.001), with the most significant difference observed along the posterior right-sided PVs (P-RPVs) and anterior left-sided PVs (A-LPVs). In logistic regression models, the mean CF was a negative predictor of PVRs along the P-RPVs and A-LPVs in the blind group (odds ratios, 0.728 and 0.786; P < 0.001 and 0.007), while no significant predictor was identified in the CF group or elsewhere in the blind group. In the Kaplan-Meier analysis, the arrhythmia-free survival rate at 12 months was 89.9% in the CF group and 88.2% in the blind group, respectively (P = 0.624). CONCLUSIONS: CF-guided CPVI can reduce PVRs and the procedural time and be particularly beneficial along regions where a relatively low CF tends to be applied: the P-RPVs and A-LPVs. The comparable clinical outcomes may be due to the learning curve effect obtained by the CF-guided technique and repeated provocation of dormant PV conduction.
Authors: Jason G Andrade; George Monir; Scott J Pollak; Paul Khairy; Marc Dubuc; Denis Roy; Mario Talajic; Marc Deyell; Léna Rivard; Bernard Thibault; Peter G Guerra; Stanley Nattel; Laurent Macle Journal: Heart Rhythm Date: 2014-07-25 Impact factor: 6.343
Authors: Marcin Kowalski; Margaret M Grimes; Francisco J Perez; David N Kenigsberg; Jayanthi Koneru; Vigneshwar Kasirajan; Mark A Wood; Kenneth A Ellenbogen Journal: J Am Coll Cardiol Date: 2012-03-06 Impact factor: 24.094
Authors: Andrea Natale; Vivek Y Reddy; George Monir; David J Wilber; Bruce D Lindsay; H Thomas McElderry; Charan Kantipudi; Moussa C Mansour; Daniel P Melby; Douglas L Packer; Hiroshi Nakagawa; Baohui Zhang; Robert B Stagg; Lee Ming Boo; Francis E Marchlinski Journal: J Am Coll Cardiol Date: 2014-08-19 Impact factor: 24.094
Authors: Chan-Il Park; Heiko Lehrmann; Cornelius Keyl; Reinhold Weber; Jochen Schiebeling; Juergen Allgeier; Patrick Schurr; Ashok Shah; Franz-Josef Neumann; Thomas Arentz; Amir S Jadidi Journal: J Cardiovasc Electrophysiol Date: 2014-04-02
Authors: Shouvik Haldar; Julian W E Jarman; Sandeep Panikker; David G Jones; Tushar Salukhe; Dhiraj Gupta; Gareth Wynn; Wajid Hussain; Vias Markides; Tom Wong Journal: Int J Cardiol Date: 2012-12-04 Impact factor: 4.164
Authors: Aamir Cheema; Jun Dong; Darshan Dalal; Joseph E Marine; Charles A Henrikson; David Spragg; Alan Cheng; Saman Nazarian; Kenneth Bilchick; Sunil Sinha; Daniel Scherr; Ibrahim Almasry; Henry Halperin; Ronald Berger; Hugh Calkins Journal: J Cardiovasc Electrophysiol Date: 2007-04
Authors: Allyson L Varley; Omar Kreidieh; Brigham E Godfrey; Carolyn Whitmire; Susan Thorington; Benjamin D'Souza; Steven Kang; Shrinivas Hebsur; Bipin K Ravindran; Edwin Zishiri; Brett Gidney; Matthew B Sellers; David Singh; Tariq Salam; Mark Metzl; Alex Ro; Jose Nazari; Westby G Fisher; Alexandru Costea; Anthony Magnano; Saumil Oza; Gustavo Morales; Anil Rajendra; Joshua Silverstein; Paul C Zei; Jose Osorio Journal: J Interv Card Electrophysiol Date: 2021-07-02 Impact factor: 1.900